Proposed Collection; Comment Request; Simulations for Drug Related Science Education, 63495-63496 [E8-25356]

Download as PDF Federal Register / Vol. 73, No. 207 / Friday, October 24, 2008 / Notices Dated: October 16, 2008. Jeffrey Shuren, Associate Commissioner for Policy and Planning. [FR Doc. E8–25359 Filed 10–23–08; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration jlentini on PROD1PC65 with NOTICES Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC); Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92–463), notice is hereby given of the following meeting: Name: Advisory Committee on Heritable Disorders in Newborns and Children. Date And Time: November 24, 2008, 1 p.m.–4 p.m. EST Place: Webcast. The ACHDNC will meet on Monday, November 24, 2008 from 1 p.m. to 4 p.m. EST. The general public can join the meeting via webcast by logging onto https://altarum.na3.acrobat.com/ achdnc/; next select ‘‘enter as a guest,’’ type in your full name, and click ‘‘enter room.’’ Participants must also dial the toll free phone number for audio (listen only). The dial-in number is 1 (877) 705–6006; when prompted say the password ‘‘HRSA Genetics’’. Participants should call no later than 12:50 p.m. EST in order for the logistics to be established for participation in the call. Meeting Registration: General public participants are asked to register for the conference by going to the registration Web site at https://events.SignUp4.com/ ACHDNC1124. The registration deadline is Friday, November 21, 2008. If there are technical problems gaining access to the call, please contact Brigitte Abu-Hamed, Meetings Coordinator, Conference and Meetings Management, Altarum Institute, telephone (202) 828– 5100, or e-mail Brigitte.AbuHamed@altarum.org. Special Accomodations: Attendees requiring special needs such as large print materials or additional special needs may make comments when registering at the online Web site. Or you may wish to contact Tamar R. Shealy, Senior Meetings Manager, Conference and Meetings Management, Altarum Institute; telephone (202) 828– 5100, or e-mail Tamar.Shealy@altarum.org. Agenda: The meeting will include presentations and continued VerDate Aug<31>2005 16:48 Oct 23, 2008 Jkt 217001 discussions on the nomination/ evaluation process for newborn screening candidate conditions for review by the ACHDNC for inclusion on the uniform newborn screening panel. Agenda items are subject to change as priorities dictate. You can also locate the Agenda, presentations, and meeting materials at the home page of the Web site at https://events.SignUp4.com/ ACHDNC1124. Public Comments: Members of the public can present oral comments during the public comment period of the conference call. Those individuals are required to register at the web site, https://events.SignUp4.com/ ACHDNC1124. Requests will contain the name, address, telephone number, and any professional or business affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. Each public commentator will be notified by email of their assigned presentation time. Members of the public are required to submit written comments that will be distributed to Committee members prior to the conference call. Parties wishing to submit written comments should ensure that the comments are postmarked or emailed no later than Friday, November 21, 2008, for consideration. Comments should be submitted to Tamar R. Shealy, Meetings Manager, Conference and Meetings Management, Altarum Institute, 1200 18th Street, NW., Suite 700, Washington, DC 20036; telephone (202) 828–5100, fax (202) 785–3083, or e-mail Tamar.Shealy@altarum.org. For Further Information Contact: Anyone requiring information regarding the ACHDNC should contact: Jill F. Shuger, M.S., Maternal and Child Health Bureau, HRSA, Parklawn Building, Room 18A–19, 5600 Fishers Lane, Rockville, Maryland 20857; telephone (301) 443–1080, fax (301) 594–0878, or e-mail jshuger@hrsa.gov. Supplementary Information: The ACHDNC was chartered originally under Section 1111 of the Public Health Service (PHS) Act, 42 U.S.C. 300b–10 in February 2003 to advise the Secretary of the U.S. Department of Health and Human Services and as amended in the Newborn Screening Saves Lives Act. The Committee is governed by the provisions of Public Law 92–463, as amended (5 U.S.C. App. 2), and 41 CFR Part 102–3, which sets forth standards for the formation and use of advisory committees. The ACHDNC is directed to review and report regularly on newborn PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 63495 and childhood screening practices for heritable disorders and to recommend improvements in the national newborn and childhood heritable screening programs. Dated: October 17, 2008. Alexandra Huttinger, Director, Division of Policy Review and Coordination. [FR Doc. E8–25449 Filed 10–23–08; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Proposed Collection; Comment Request; Simulations for Drug Related Science Education Summary: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institute on Drug Abuse (NIDA), the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on June 26, 2008, (Vol. 73 No. 124, page 36337) and allowed 60 days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after November 15, 2008, unless it displays a currently valid OMB control number. Proposed Collection: Title: Simulations for Drug Related Science Education. Type of Information Collection Request: NEW. Need and Use of Information Collection: This is a request for a one-time clearance to evaluate an interactive multimedia module developed by ArchieMD. This evaluation seeks to determine whether the multimedia module ArchieMD: The Science of Drugs (1) Increases students’ knowledge in brain and heart biology and the effects drugs have on the body (2) Increases positive attitudes towards science education for high school students (3) Reinforces or instills negative attitudes towards substance abuse. In order to test the effectiveness of the interactive multimedia module, data will be collected in the form of pre and post test surveys from 10th and 11th grade high school students utilizing the developed module. The E:\FR\FM\24OCN1.SGM 24OCN1 63496 Federal Register / Vol. 73, No. 207 / Friday, October 24, 2008 / Notices findings will provide valuable information regarding information pertaining to the use of interactive multimedia educational modules in high school science classrooms and their ability to increase knowledge and change attitudes and perceptions. Frequency of Response: 4. Affected Public: High school students engaged with the ArchieMD: The Science of Drugs program. Type of Respondent: Participants will include high school students enrolled in the tenth and eleventh grade. Estimated Total Annual Number of Respondents: 360. Estimated Number of Responses per Respondent: 4. Average Burden Hours per Response: Number of respondents Type of respondents One high school period lasting 50 minutes. Estimated Total Annual Burden Hours Requested: 1,199.95. There are no Capital Costs to report. There are no Operating or Maintenance Costs to report. The estimated annualized burden is summarized below. Frequency of response Average burden hours per response Estimated total burden hours requested 360 4 .8333 1,199.95 Total .......................................................................................................... jlentini on PROD1PC65 with NOTICES Participants—High School Students ................................................................ 360 4 .8333 1,199.95 Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (2) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, New Executive Office Building, Room 10235, Washington, DC 20503, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Dr. Cathrine Sasek, Coordinator, Science Education Program, Office of Science Policy and Communications, National Institute on Drug Abuse, 6001 Executive Blvd., Room 5237, Bethesda, MD 20892, or call non-toll-free number (301) 443– 6071; fax (301) 443–6277; or by e-mail to csasek@nida.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. VerDate Aug<31>2005 16:48 Oct 23, 2008 Jkt 217001 Dated: October 16, 2008. Mary Affeldt, Associate Director for Management, National Institute on Drug Abuse. [FR Doc. E8–25356 Filed 10–23–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Metabolic Endocrinology. Date: November 4–5, 2008. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Reed A. Graves, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6166, MSC 7892, Bethesda, MD 20892, (301) 402– 6297, gravesr@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 limitations imposed by the review and funding cycle. Name of Committee: AIDS and Related Research Integrated Review Group, AIDS Clinical Studies and Epidemiology Study Section. Date: November 6, 2008. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Hilary O. Sigmon, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5222, MSC 7852, Bethesda, MD 20892, (301) 594– 6377, sigmonh@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Skeletal Biology. Date: November 10–14, 2008. Time: 7 p.m. to 8 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Priscilla B. Chen, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4104, MSC 7814, Bethesda, MD 20892, (301) 435– 1787, chenp@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; AIDS SBIR/ STTR Biological Sciences. Date: November 12–14, 2008. Time: 9 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Kenneth A. Roebuck, PhD, Scientific Review Officer, Center for E:\FR\FM\24OCN1.SGM 24OCN1

Agencies

[Federal Register Volume 73, Number 207 (Friday, October 24, 2008)]
[Notices]
[Pages 63495-63496]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-25356]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed Collection; Comment Request; Simulations for Drug 
Related Science Education

    Summary: Under the provisions of Section 3507(a)(1)(D) of the 
Paperwork Reduction Act of 1995, the National Institute on Drug Abuse 
(NIDA), the National Institutes of Health (NIH) has submitted to the 
Office of Management and Budget (OMB) a request for review and approval 
of the information collection listed below. This proposed information 
collection was previously published in the Federal Register on June 26, 
2008, (Vol. 73 No. 124, page 36337) and allowed 60 days for public 
comment. No public comments were received. The purpose of this notice 
is to allow an additional 30 days for public comment. The National 
Institutes of Health may not conduct or sponsor, and the respondent is 
not required to respond to, an information collection that has been 
extended, revised, or implemented on or after November 15, 2008, unless 
it displays a currently valid OMB control number.
    Proposed Collection: Title: Simulations for Drug Related Science 
Education. Type of Information Collection Request: NEW. Need and Use of 
Information Collection: This is a request for a one-time clearance to 
evaluate an interactive multimedia module developed by ArchieMD. This 
evaluation seeks to determine whether the multimedia module ArchieMD: 
The Science of Drugs (1) Increases students' knowledge in brain and 
heart biology and the effects drugs have on the body (2) Increases 
positive attitudes towards science education for high school students 
(3) Reinforces or instills negative attitudes towards substance abuse. 
In order to test the effectiveness of the interactive multimedia 
module, data will be collected in the form of pre and post test surveys 
from 10th and 11th grade high school students utilizing the developed 
module. The

[[Page 63496]]

findings will provide valuable information regarding information 
pertaining to the use of interactive multimedia educational modules in 
high school science classrooms and their ability to increase knowledge 
and change attitudes and perceptions.
    Frequency of Response: 4. Affected Public: High school students 
engaged with the ArchieMD: The Science of Drugs program. Type of 
Respondent: Participants will include high school students enrolled in 
the tenth and eleventh grade. Estimated Total Annual Number of 
Respondents: 360. Estimated Number of Responses per Respondent: 4. 
Average Burden Hours per Response: One high school period lasting 50 
minutes. Estimated Total Annual Burden Hours Requested: 1,199.95. There 
are no Capital Costs to report. There are no Operating or Maintenance 
Costs to report. The estimated annualized burden is summarized below.

----------------------------------------------------------------------------------------------------------------
                                                                                                     Estimated
                                                     Number of     Frequency of   Average burden   total burden
               Type of respondents                  respondents      response        hours per         hours
                                                                                     response        requested
----------------------------------------------------------------------------------------------------------------
Participants--High School Students..............             360               4           .8333        1,199.95
                                                 ---------------------------------------------------------------
    Total.......................................             360               4           .8333        1,199.95
----------------------------------------------------------------------------------------------------------------

    Request for Comments: Written comments and/or suggestions from the 
public and affected agencies are invited on one or more of the 
following points: (1) Whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information shall have practical utility; (2) the 
accuracy of the agency's estimate of the burden of the proposed 
collection of information; (3) ways to enhance the quality, utility, 
and clarity of the information to be collected; and (4) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, New Executive Office Building, Room 10235, Washington, DC 
20503, Attention: Desk Officer for NIH. To request more information on 
the proposed project or to obtain a copy of the data collection plans 
and instruments, contact: Dr. Cathrine Sasek, Coordinator, Science 
Education Program, Office of Science Policy and Communications, 
National Institute on Drug Abuse, 6001 Executive Blvd., Room 5237, 
Bethesda, MD 20892, or call non-toll-free number (301) 443-6071; fax 
(301) 443-6277; or by e-mail to csasek@nida.nih.gov.
    Comments Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30 days 
of the date of this publication.

    Dated: October 16, 2008.
Mary Affeldt,
Associate Director for Management, National Institute on Drug Abuse.
[FR Doc. E8-25356 Filed 10-23-08; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.